John is a member of the firm’s Washington, D.C., office and a former federal prosecutor and Assistant Director at the U.S. Department of Justice (DOJ). He represents clients across the healthcare and life sciences spectrum, from emerging and growth-stage technology, wellness, and medical product companies to large publicly traded corporations, in all matters that implicate FDA litigation, enforcement, and compliance under the Food, Drug, and Cosmetic Act (FDCA).
